Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
IT0004147952
Tue, 01.04.2025
Newron Pharmaceuticals S.p.A.
Newron presents 2024 financial results and provides 2025 outlook
Milan, Italy, April 1, 2025, 07:00 am CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its financ [ … ]
Mon, 24.03.2025
Newron Pharmaceuticals S.p.A.
Newron proposes renowned biopharma company founder and entrepreneur Dr. Chris Martin for election as Independent Chairman
Expected to succeed Dr. Ulrich Köstlin who has notified Newron of his intention to retire after 12 years of service as Chairman of its Board of Directors, effective following completion of this year’s AGM
Chris Martin, forme [ … ]
Thu, 09.01.2025
Newron Pharmaceuticals S.p.A.
Newron and Myung In Pharm announce license agreementfor evenamide in South Korea
Myung In Pharm to develop, manufacture and commercialize evenamide in South Korea
Myung In Pharm to contribute 10% of patients to Newron’s pivotal Phase III trial for evenamide, and share global development costs
Newron will receive upfront payment, development and [ … ]